Remove 2011 Remove Dermatitis Remove Partnerships
article thumbnail

WHO Foundation, L’Oréal Groupe Join Forces to Improve Skin Health Worldwide

The Dermatology Digest

The WHO Foundation and the LOral Groupe , spearheaded by its Dermatological Beauty Division, are launching a four-year partnership to expand access to the treatment of skin conditions worldwide. The post WHO Foundation, LOral Groupe Join Forces to Improve Skin Health Worldwide appeared first on The Dermatology Digest.

article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

Mr. Raducha-Grace recently served as Head of Clinical Partnerships at Harbor Health. The company is also conducting a 250-patient phase 2b trial of its topical JAK 1/3 inhibitor, called ATI-1777 in atopic dermatitis. Before Harbor Health, he led product and go-to-market functions for CVS’s kidney care and home business units.